Professor Oliver A. Cornely, MD FACP, FIDSA, FAAM, FECMM

Oliver Cornely is a Full Professor, Director & Chair of the Institute of Translational Research at the CECAD Center of the University of Cologne, and Scientific Director of the Center for Clinical Trials. Clinically, he serves as Infectious Diseases Consultant at the University Hospital of Cologne, Germany. He is board certified in internal medicine, infectious diseases, hematology and oncology, and holds degrees in medical mycology, emergency medicine and travel medicine. Originating from an HIV/AIDS clinical research group, Prof. Cornely’s research interest centers on infections in immunocompromised hosts, including invasive fungaldiseases, antimicrobial resistance, Clostridioides difficile infection, and vaccine preventable diseases. Oliver Cornely is past President of the European Confederation of Medical Mycology (ECMM), the roof organization of 28 national mycology societies, and did set up the ECMM Global Guideline Program, ECMM Academy (Fellows program), and ECMM Excellence Center Initiative, designating clinical and microbiological excellence centers after an international audit procedure. He is founder and chair of the Infectious Diseases Scientific Working Group of the European Hematology Association (EHA). Oliver Cornely is president-elect of the International Society for Human and Animal Mycology (ISHAM) and serves as Chair of the Infectious Diseases Working Party (AGIHO), a working group of the German Society for Haematology and Oncology (DGHO). He is site spokesman for Bonn/Cologne for the German Center for Infection Research (DZIF). He served on the Board of Directors of the Mycoses Study Group – Education and Research Council (MSGERC) and on the Standards and Practice Guidelines Committee of the Infectious Diseases Society of America (IDSA). Oliver Cornely currently collaborates with mycologists in 93 countries on rare fungal infections and on tailoring management guidelines to health care settings throughout the world. In January 2021, he founded the VACCELERATE Site Network European Commission. It currently comprises 525 institutes in 57 countries accelerating vaccine development against pathogens of pandemic potential. He published over 700 peer-reviewed articles, books, book chapters, and electronic media; runs the YouTube® channel ID in MotionTM, and ranks among the Top 1% most cited researchers. He is a reviewer for numerous medical scientific journals, editorial board member for Haematologica and Infectious Disease, and Editor-in-Chief of Mycoses.